Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001147BKPyvENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS46001326BKPyvENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS42001156EBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10009443HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10009444HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10010334HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10007991HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10009525HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10010594HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS10012210HBVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TCGA Plot Options
Drug Information
GenePDE3A
DrugBank IDDB00922
Drug NameLevosimendan
Target IDBE0000436
UniProt IDQ14432
Regulation Typeinhibitor
PubMed IDs16116344
CitationsSzilagyi S, Pollesello P, Levijoki J, Haikala H, Bak I, Tosaki A, Borbely A, Edes I, Papp Z: Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. J Cardiovasc Pharmacol. 2005 Sep;46(3):369-76.
GroupsApproved; Investigational
Direct ClassificationPhenylhydrazines
SMILESC[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
Pathways
PharmGKBPA164749138
ChEMBLCHEMBL2051955